Stellate ganglion block (SGB) is a procedure used for the treatment and diagnosis of disorders mediated by the sympathetic nervous system. These disorders include complex regional pain syndrome, acute herpes zoster, postherpetic neuralgia, hyperhidrosis and vascular disease such as Raynaud's disease ([@b1-prm-20-305]--[@b6-prm-20-305]). The sympathetically maintained pain is diagnosed clinically by evaluating the analgesic effect of sympathetic block (SB) ([@b7-prm-20-305]). SB leads to vascular relaxation, which results in improved blood flow. However, an objective marker of successful SGB does not exist, and Horner syndrome, which is used to determine the effect of SGB, is sometimes not clearly present. An objective way to identify increased blood flow in the upper extremity after SGB would be helpful. Pulse transit time (PTT) is defined as the time required for the arterial pulse pressure wave to travel from the aortic valve to the periphery, and can be used as an index of the increased blood flow resulting from the decrease in arterial resistance after SB ([@b8-prm-20-305],[@b9-prm-20-305]). For this reason, we hypothesized that PTT measurements would be significantly associated with a successful block. The aim of the present pilot study was to investigate the change in PTT after SGB and to evaluate the usefulness of PTT as an objective measurement tool for successful SGB.

METHODS
=======

The protocol for the present prospective pilot study was approved by the Institutional Review Board of the Asan Medical Center (Seoul, Republic of Korea) and was registered at the University of Ulsan (Seoul, Republic of Korea) under the number S2013-0866-0002. Patients between 34 and 62 years of age on whom SGB was performed for the diagnosis or treatment of sympathetically mediated neuropathic pain of the upper extremities were enrolled in the Pain Clinic at Asan Medical Center. All eligible patients were able to understand the study protocol, provide informed consent and participate in outcome measurements. Exclusion criteria were: diseases that can influence the vascular system such as vascular or valvular disease; use of antihypertensive medicine; and the presence of arrhythmia, diabetes or Raynaud's phenomenon. Patients with an essential tremor in the upper extremity or a history of adverse reactions to local anesthetics were also excluded. SGB was performed under ultrasound guidance by one pain specialist at Asan Medical Center. Although the stellate ganglion is located at the C7-T1 vertebral level, SGB was performed at the C6 vertebral level because the vertebral artery is located in front of the anterior tubercle of C7. The cricoid cartilage is a landmark of the level of the C6 vertebra in the neutral supine position, and the target using the ultrasound-guided approach is the anterior tubercle of the C6 transverse process. The tip of the needle is located in the fascial plane where the stellate ganglion runs and is superficial to the fascia investing the longus colli muscle. Subsequently, 8 mL of 1% lidocaine was injected to produce a sympathetic block. After completion of the procedure, each patient was assessed for any signs of complications after the block. The sympatholytic effect after SGB was measured by examining for the presence of Horner syndrome (ptosis, miosis, red conjunctiva and facial anhidrosis). Electrocardiography (ECG), noninvasive blood pressure measurements and a pulse oximeter were used in all patients. All monitoring values measured by a patient monitor (IntelliVue MP 60; Philips, Netherlands) were recorded automatically in real time on an interlocking computer program (version 1.0, Leomedics, Korea). Monitoring began before performing the procedure and continued for 10 min after the injection of local anesthetics. The success of SGB was determined by confirming the presence of Horner syndrome. PTT was measured using saved data on the WinDaq waveform browser (DATAQ Instruments, USA). It was defined as the time between the appearance of the R wave on the ECG and the highest point of the corresponding wave on a plethysmogram, and was presented in milliseconds ([Figure 1](#f1-prm-20-305){ref-type="fig"}).

Data analysis
-------------

SPSS version 21 (IBM Corporation, USA) for Windows (Microsoft Corporation, USA) was used for data analysis; mean ± SD and inferential statistics were obtained using the nonparametric Friedman test. P\<0.05 was considered to be statistically significant.

RESULTS
=======

A total of eight patients (seven female, one male) were included. The patients had: a cervical herniated intervertebral disc with sympathetically maintained pain (burning dysesthetic pain, swelling, hyperhidrosis) (n=3); postherpetic neuralgia (n=2); complex regional pain syndrome (n=2); or central neuropathic pain (n=1). The SGBs were successful in eight (100%) cases ([Table 1](#t1-prm-20-305){ref-type="table"}). An average PTT value was obtained, which was measured from five consequent waves. PTT was measured at baseline (PTT0) and 3 min (PTT3), 5 min (PTT5) and 10 min (PTT10) after the injection of lidocaine ([Table 2](#t2-prm-20-305){ref-type="table"}).

At 3 min after SGB (PTT3), the mean PTT was 624.6±20.5 ms. At 5 min after injection (PTT5), the mean PTT was 630.8±17.5 ms. Prolonged PTT at 5 min returned to baseline at 10 min (613.6±14.7 ms).

According to the Friedman test, the differences from baseline were significant (P=0.008) ([Figure 2](#f2-prm-20-305){ref-type="fig"}).

DISCUSSION
==========

To our knowledge, changes in PTT after SGB have not previously been studied. We investigated the relationship between the change of PTT and the presence of clinical signs after SGB in patients with sympathetically mediated pain of the upper extremities to determine whether PTT could be used to verify the success of SGB. We found that changes in PTT can objectively predict a successful SGB after only 5 min. This highly significant correlation was achieved with no complications. No patients dropped out of the present pilot study.

The stellate ganglion is part of the cervical sympathetic trunk and lies immediately anterior to the anterior tubercle of the C7 vertebrae. The sympathetic supply to the head, neck and upper limb is derived from the thoracic segments 1 to 9 and passes through the stellate ganglion ([@b1-prm-20-305],[@b3-prm-20-305]). An SGB is an injection of local anesthetic for pain located in the arm, chest, neck or head that is caused by sympathetically maintained pain resulting from reflex sympathetic dystrophy, postherpetic neuralgia, herpes zoster, causalgia or intractable angina ([@b10-prm-20-305]). SGB also has an established use in treating patients with disorders mediated by circulatory insufficiency such as Raynaud's phenomenon or CREST syndrome. We performed a total of eight SGBs using our ultrasound-guided approach. The ultrasound-guided approach is a safe and valuable tool for confirming the spread of local anesthetics in the adequate fascial plane without risking exposure to radiation, and for guiding needle advancement ([@b11-prm-20-305]). The stellate ganglion lies on the longus colli muscle at the C7-T1 vertebral level ([@b12-prm-20-305]). Several studies have suggested that the local anesthetic solution would be discharged around and within the longus colli muscle during SGB ([@b13-prm-20-305]). However, if the local anesthetic is not injected into the proper location, the sympatholytic effect cannot be identified in the upper limbs ([@b6-prm-20-305]). We believe that the strength of PTT measurement can detect these misplaced blocks in the upper limb using a pulse oximeter sensor placed over the ipsilateral index finger.

Ipsilateral Horner syndrome (facial anhidrosis, ptosis, miosis and red conjunctiva) is well known in patients after a successful SGB ([@b14-prm-20-305]). However, Horner syndrome can only subjectively predict a successful block. Also, in some patients, these signs can be ambiguous for the evaluation of a successful block and there are no concrete defined criteria ([@b6-prm-20-305]). In particular, it is known that the sympathetic function of the upper extremity is not blocked successfully by SGB, although the presence of clinical signs, such as anhidrosis, miosis, hypohidrosis, enophthalmos and bloodshot conjunctiva can be used as criteria ([@b7-prm-20-305],[@b15-prm-20-305],[@b16-prm-20-305]). Another conventional method for evaluating SGB is the change in temperature. Sympatholysis was measured in terms of the increase in temperature in the ipsilateral extremity after the block, and the increase in temperature was compared with that of the contralateral extremity ([@b17-prm-20-305]). However, Krumova et al ([@b7-prm-20-305]) reported that a skin temperature measurement is required to verify ipsilateral sympathicolysis at least 90 min after the intervention. To address the weak points of previous measurements, many recent clinical trials have been introduced to verify the efficacy of SGB. Yamazaki et al ([@b6-prm-20-305]) reported that continuous measurements of the perfusion index using pulse oximetry could be useful in the determination of the efficacy of SGB. Murakawa et al ([@b18-prm-20-305]) examined blood flow in the common carotid artery using an ultrasonic blood flow meter. They demonstrated that the common carotid artery blood flow increased after blocking SGB. Rogowski et al ([@b19-prm-20-305]) reported that thermographic examination of the upper extremity on the ipsilateral side of stellate blockade is a useful diagnostic tool for the assessment of SGB. Compared with these measurement tools, PTT measurement is easy to use, inexpensive, and rapid and safe for assessing SGB objectively. To measure PTT, only three external ECG and photoplethysmographic sensors, which are basic and noninvasive monitoring devices, are required. Clinically, PTT changes can be used as a noninvasive beat-to-beat index of arterial pressure changes. Sympatholysis changes arterial distensibility via vasodilation and leads to a decrease of pulse wave velocity (PWV), which is a parameter of arterial distensibility ([@b20-prm-20-305],[@b21-prm-20-305]). PTT is inversely related to PWV ([@b20-prm-20-305]). SB also decreases systemic vascular resistance (SVR). Thus, we assume that a lower SVR will result in lower tension of the arterial wall and a higher PTT, although further studies are required to examine these relationships. PWV can be determined by measuring the PTT of blood, whose flow fixes the distance of the blood vessel indirectly ([@b20-prm-20-305]). Because of this, several studies have been performed. Kortekaas et al ([@b22-prm-20-305]) reported that the mean PTT difference increased significantly after a successful axillary brachial plexus blockade. They concluded that PTT is a reliable method to evaluate whether a brachial plexus block is going to be successful. Sharwood-Smith et al ([@b21-prm-20-305]) found that PTT may be used to predict the onset of hypotension because PTT measurements give a beat-to-beat change of arterial pressure during spinal anesthesia in obstetric patients. In the present study, we investigated the success of SGB by performing PTT measurements on eight patients treated with SGB. All patients had Horner syndrome and PTT of the ipsilateral hand was prolonged at 5 min after SGB. This enabled us to predict successful SGB objectively. We also found that a prolonged PTT at 5 min returned to the baseline value at 10 min. To our knowledge, there have been no previous reports regarding this phenomenon. We assume that the increased blood flow after SGB returns to normal via a redistribution of arterial blood flow, and it may take 10 min. The PTT is a simplified surrogate marker to reflect blood flow, and may be affected by several mechanisms controlling the blood flow. We could not interpret this phenomenon exactly. However, we assumed that the change in PTT, not the value of PTT itself, reflect the change in blood flow and not the absolute value of blood flow. Therefore, the PTT increment was only shown during the time when the blood flow increased and then normalized because the blood flow maintained the increased state. Further investigation will be required to determine the time for redistribution.

There were several limitations to the present study. First, the number of patients was relatively small, suggesting the risk of an undersampling error. The results of our pilot study indicate a need for a larger, well-powered, properly conducted trial. The second limitation was that PTT may be affected by movement artifacts, which can cause artifacts in photoplethysmography signals. Fluctuations in the arousal state can lead to fluctuations in PTT and, thus, false scoring. The third limitation was that we did not compare the prolongation of the PTT with thermography in clinical trials, although thermography is a useful tool for the assessment of SGB effectiveness. In future studies, the correlation between PTT changes and thermographic changes should be elucidated in patients undergoing SGB. The fourth limitation was that we could not measure the response in the contralateral side as a control because our monitoring and recording system supported only one channel for the plethysmography. To overcome this point, we measured baseline PTT and considered this value as a control. The fifth limitation was that patients with Raynaud's phenomenon were excluded. Raynaud's phenomenon is associated with excessively reduced blood flow in response to emotional stress, causing discoloration of the fingers, and is believed to be the result of vasospasm that decreases blood supply to the extremities. Thus, we assumed Raynaud's phenomenon could affect experimental outcomes during PTT measurement. If possible, further investigations involving patients with Raynaud's phenomenon should be performed to evaluate the changes in PTT after SGB.

Despite these limitations, the present study suggests that measurement of PTT at 5 min after local anesthetic injection can help to objectively determine whether SGB was successful.

CONCLUSION
==========

To our knowledge, the present study was the first to measure the effect of SGB on PTT. The results of our study showed that the change in PTT during the 5 min after local anesthetic injection can help to determine whether SGB has been successful. This would allow PTT to be a potential measurement tool that is noninvasive, safe, easy to use and a rapid method of objectively assessing the success of SGB. However, comparisons with other tests, such as thermography, would be needed to support the clinical validity of these results.

![*The pulse transit time monitoring equipment. Electrocardiography and a pulse oximeter were used in all patients. All monitoring values measured by a patient monitor (IntelliVue MP 60; Philips, Netherlands) were recorded automatically in real time on an interlocking computer program (version 1.0, Leomedics, Korea). Pulse transit time was measured using the saved data on the WinDaq*^®^ *waveform browser. SGB Stellate ganglion block; USG Ultrasound*](prm-20-305-1){#f1-prm-20-305}

![Box plot of data reflecting changes in mean pulse transit time (PTT) (ms) at baseline (PTT0) and 3 min (PTT3), 5 min (PTT5) and 10 min (PTT10) after the injection of the local anesthetic](prm-20-305-2){#f2-prm-20-305}

###### 

Patient characteristics

  **Patient**   **Sex**   **Age, years**   **Diagnosis**                                        **SGB level**   **Location**   **Horner sign**
  ------------- --------- ---------------- ---------------------------------------------------- --------------- -------------- -----------------
  1             Female    55               PHN                                                  C6              Left           Yes
  2             Female    62               C-HIVD with SMP                                      C6              Right          Yes
  3             Male      58               PHN                                                  C6              Right          Yes
  4             Female    55               C-HIVD with SMP                                      C6              Left           Yes
  5             Female    52               C-HIVD with SMP                                      C6              Left           Yes
  6             Female    56               CRPS type I                                          C6              Right          Yes
  7             Female    49               Central neuropathic pain                             C6              Left           Yes
  8             Female    34               CRPS type II with an effect of brachial plexopathy   C6              Right          Yes

CRPS Complex regional pain syndrome; C-HIVD Cervical herniated intervertebral disc; PHN Postherpetic neuralgia; SGB Stellate ganglion block; SMP Sympathetically maintained pain

###### 

Average value of pulse transit time (PTT), measured from five consequent waves

  **Patient**   **PTT0**   **PTT3**   **PTT5**   **PTT10**
  ------------- ---------- ---------- ---------- -----------
  1             592        646.55     642        632
  2             616.8      612.7      624.3      619.6
  3             590.7      615.7      629        611
  4             559.7      598        603.3      591.3
  5             626.8      613.6      635.2      622.4
  6             655.6      658        664.4      610.8
  7             587.2      614        622.8      594.4
  8             606.8      638.4      625.6      627.2

PTT values presented in milliseconds. PTT0 PTT at baseline; PTT3 PTT 3 min after the injection of the local anesthetic; PTT5 PTT 5 min after the injection of the local anesthetic; PTT10 PTT 10 min after the injection of the local anesthetic
